Cart
sales@molnova.com
3-Phenylbutyric acid
CAS No. 4593-90-2
3-Phenylbutyric acid( —— )
Catalog No. M27054 CAS No. 4593-90-2
3-Phenylbutyric acid isolates Rhodococcus rhodochrous PB1 from compost soil and is metabolized by initial oxidation of the benzene ring and by initial oxidation of the side chain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 67 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Phenylbutyric acid
-
NoteResearch use only, not for human use.
-
Brief Description3-Phenylbutyric acid isolates Rhodococcus rhodochrous PB1 from compost soil and is metabolized by initial oxidation of the benzene ring and by initial oxidation of the side chain.
-
Description3-Phenylbutyric acid isolates Rhodococcus rhodochrous PB1 from compost soil and is metabolized by initial oxidation of the benzene ring and by initial oxidation of the side chain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorprogesterone receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4593-90-2
-
Formula Weight164.204
-
Molecular FormulaC10H12O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (609.01 mM)
-
SMILESCC(CC(O)=O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Griesinger G, et al. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis. PLoS One. 2020 Nov 4;15(11):e0241044.
molnova catalog
related products
-
4-Methoxycoumarine
4-Methoxycoumarine has antitumour effects.Coumarin has antitumour effects in vivo and cytostatic effects in vitro. Its half-life in humans is short (1-1.5 h) and the monohydroxylated biotransformation products have significantly longer half-lives.
-
VU 0357017 hydrochlo...
VU 0357017 hydrochloride is highly selective M1 agonists act at an allosteric site to activate the receptor (EC50: 477 ± 172 nM; Pec50: 6.37 ± 0.15).
-
SM4
SM4 is a SOX18 small molecule inhibitor of HemSC vessel formation in vivo.
